CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Precision Flow Plus +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03885726
NCT03885726N/ACompleted
CompareCT.gov

Assessing Clinical Effect of HVNI on Patient Ambulation in Acute Care Scenarios: a Feasibility Study

Vapotherm, Inc.·interventional·Posted Mar 22, 2019·Updated Oct 19, 2020

In Brief

A clinical study evaluating Precision Flow Plus and Treatment as Usual for Respiratory Insufficiency and Dyspnea. Completed, enrolled 32 participants across 3 sites.

Detailed Summary

The pilot/feasibility study evaluates the ability of High Velocity Nasal Insufflation (HVNI) therapy to facilitate ambulation and mobilization in patients experiencing shortness of breath, as compared to simple oxygen therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRespiratory Insufficiency, Dyspnea
CountriesUnited States
CollaboratorsKnox Community Hospital, Riverside Medical Center, Midwest Chest Consultants

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 22, 2019
Enrollment StartNov 21, 2018
Primary CompletionFeb 28, 2019
Study CompletionMar 11, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.3 years ago

Interventions

Precision Flow Plusdevice

High velocity nasal insufflation

Treatment as Usualdevice

Conventional therapy per institution